Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    A system for manually or automatically controlled gustatory stimulation

    I. Andersson, G. Hellekant, R. Larsson, C. Molander in Medical and biological engineering (1971)

  2. No Access

    Article

    Oral absorption of cimetidine and its clearance in patients with renal failure

    The plasma concentration curve after a single oral dose of cimetidine 200 mg was followed in 27 patients with varying degrees of chronic renal failure (creatinine clearance 1–52 ml/min) and in 46 patients with...

    R. Larsson, G. Bodemar, B. Norlander in European Journal of Clinical Pharmacology (1979)

  3. No Access

    Article

    Pharmacokinetics of cimetidine and its sulphoxide metabolite during haemodialysis

    A single intravenous dose of cimetidine 200mg was administered to 6 patients with severe chronic renal failure one hour prior to haemodialysis. The plasma concentrations of cimetidine and its sulphoxide metabo...

    R. Larsson, P. Erlanson, G. Bodemar in European Journal of Clinical Pharmacology (1982)

  4. No Access

    Article

    Prizidilol, a combined vasodilatory and β-adrenoceptor blocking drug, in primary hypertension

    After an initial placebo period of four weeks 24 patients with primary hypertension were treated with prizidilol, a hydrazinopyridazine derivative with combined vasodilator and non-selective beta-adrenoceptor ...

    B. E. Karlberg, R. Larsson, K. P. Öhman in European Journal of Clinical Pharmacology (1983)

  5. No Access

    Article

    Pharmacokinetics of enprofylline in patients with impaired renal function after a single intravenous dose

    Enprofylline, a new bronchodilating drug, was given i.v. at 1.0 mg/kg to 7 healthy subjects and to 14 patients with differing degrees of chronic renal insufficiency. Plasma and urine concentrations of unchange...

    E. Lunell, O. Borgå, R. Larsson in European Journal of Clinical Pharmacology (1984)

  6. No Access

    Article

    Effects of probenecid on enprofylline kinetics in man

    Enprofylline 1 mg/kg, a new potent antiasthmatic xanthine derivative, which is mainly eliminated by renal excretion, was given intravenously to 6 normal subjects with and without oral pretreatment with 1 g pro...

    O. Borgå, R. Larsson, E. Lunell in European Journal of Clinical Pharmacology (1986)

  7. No Access

    Article

    Pharmacokinetics and effects on blood pressure of a single oral dose of milrinone in healthy subjects and in patients with renal impairment

    Milrinone, a new, nonglycosidic inotropic agent with peripheral vasodilating properties, was given as a single oral 5 mg dose to 7 healthy subjects, 7 patients with moderate renal impairment (CRI I, creatinine...

    R. Larsson, H. Liedholm, K. E. Andersson in European Journal of Clinical Pharmacology (1986)

  8. No Access

    Article

    Cytoplasmic Ca2+ concentration of single normal human and bovine parathyroid cells measured by dual wavelength microfluorometry

    Dual wavelength microfluorometry was utilized to measure the cytoplasmic calcium concentration (Cai 2+) of single parathyroid cells loaded with the indicator fura-2. The method enabled the first registrations of ...

    H. Johansson, R. Larsson, P. Nygren, E. Lindh, J. Rastad in Bioscience Reports (1987)

  9. No Access

    Article

    Verapamil and cyclosporin a sensitize human kidney tumor cells to vincristine in absence of membrane P-glycoprotein and without apparent changes in the cytoplasmic free Ca2+ concentration

    Vincristine (Vcr) dose dependently inhibited growth of the kidney adenocarcinoma cell line ACHN during 4 days of culture. Verapamil (Ver) at 10 μM and cyclosporin A (CsA) at 1 μg/ml had no effect on cell growt...

    P. Nygren, R. Larsson in Bioscience Reports (1990)

  10. No Access

    Article

    Doxorubicin selected multidrug-resistant small cell lung cancer cell lines characterised by elevated cytoplasmic Ca2+ and resistance modulation by verapamil in absence of P-glycoprotein overexpression

    Sublines from the small cell lung cancer (SCLC) cell lines U1285 and U1690, denoted U1285-100, U1285-250, U1690-40 and U1690-150, were adapted to grow in the continuous presence of 100, 250, 40 and 150 ng ml-1...

    P Nygren, R Larsson, A Gruber, C Peterson, J Bergh in British Journal of Cancer (1991)

  11. No Access

    Article

    In vitro testing of chemotherapeutic drug combinations in acute myelocytic leukaemia using the fluorometric microculture cytotoxicity assay (FMCA)

    The fluorometric microculture cytotoxicity assay (FMCA) was employed for analysing the effect of different chemotherapeutic drug combinations and their single constituents in 44 cases of acute myelocytic leuka...

    R Larsson, H Fridborg, J Kristensen, C Sundström, P Nygren in British Journal of Cancer (1993)

  12. No Access

    Article

    Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours

    The semiautomated fluorimetric microculture cytotoxicity assay (FMCA) was used for evaluation of the ability of cyclosporin A (CsA) and its novel non-immunosuppressive derivative SDZ PSC 833 (PSC) to modify th...

    H Fridborg, B Jonsson, P Nygren, K Csoka, K Nilsson, G Öberg in British Journal of Cancer (1994)

  13. No Access

    Article

    The cytotoxic activity of Taxol in primary cultures of tumour cells from patients is partly mediated by Cremophor EL

    In patient tumour samples the activity in vitro of Taxol corresponded fairly well to the known clinical activity and Taxol showed low cross-resistance to standard cytotoxic drugs. However, the Taxol solvent Cr...

    P Nygren, K Csoka, B Jonsson, H Fridborg, J Bergh, H Hagberg in British Journal of Cancer (1995)

  14. No Access

    Article

    Treatment of organophosphate poisoning in pigs: antidote administration by a new binary autoinjector

    The therapeutic effectiveness of a new binary autoinjector containing 500 mg HI-6 and 2 mg atropine sulphate was tested in anesthetized pigs poisoned by a lethal dose of soman i.v. (9 μg/kg per 20 min). Pharma...

    A. Göransson-Nyberg, G. Cassel, T. Jeneskog, L. Karlsson in Archives of Toxicology (1995)

  15. No Access

    Article

    Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance

    Differential drug response in a human cell line panel representing defined types of cytotoxic drug resistance was measured using the non-clonogenic fluorometric microculture cytotoxicity assay (FMCA). In total...

    S Dhar, P Nygren, K Csoka, J Botling, K Nilsson, R Larsson in British Journal of Cancer (1996)

  16. No Access

    Article

    Cytotoxic activity of cyclosporin A and [3-keto-Bmt1]-[Val2]-cyclosporin (SDZ PSC 833) on tumour cells from patients with haematological malignancies

    Objective and method: The fluorometric microculture cytotoxic assay was employed for characterisation of the cytotoxic effect of cyclosporin A (CsA) and its non-immunosuppressive analogu...

    P. Martinsson, P. Nygren, H. Fridborg in European Journal of Clinical Pharmacology (1997)

  17. No Access

    Article

    Cytotoxic activity of topotecan in human tumour cell lines and primary cultures of human tumour cells from patients

    The cytotoxic activity and cross-resistance pattern of the novel topoisomerase I inhibitor topotecan (Topo) were investigated in ten cell lines, representing different mechanisms of cytotoxic drug resistance, ...

    E Jonsson, H Fridborg, K Csóka, S Dhar, C Sundström, P Nygren in British Journal of Cancer (1997)

  18. No Access

    Article

    Comparison of the cytotoxic activity of melphalan with L-prolyl-m-L-sarcolysyl-L-p-fluorophenylalanine in human tumour cell lines and primary cultures of tumour cells from patients

    m-L-sarcolysin (m-L-SL) is an isomer of melphalan (Mel) with the di(2-chloroethyl) amino group being substituted in the meta position of phenylalanine. By covalent conjugation of amino acids to m-L-SL, a pepti...

    R Larsson, S Dhar, H Ehrsson, P Nygren, R Lewensohn in British Journal of Cancer (1998)

  19. No Access

    Article

    Synergistic interactions of combinations of topotecan with standard drugs in primary cultures of human tumor cells from patients

    Objective: Combination therapies are important in the treatment of many tumor types. This study was undertaken to find candidates for combination therapy with the novel topoisomerase I i...

    E. Jonsson, H. Fridborg, P. Nygren, R. Larsson in European Journal of Clinical Pharmacology (1998)

  20. Article

    Open Access

    Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles

    Acquired drug resistance is a major problem in cancer treatment. To explore the genes involved in chemosensitivity and resistance, 10 human tumour cell lines, including parental cells and resistant subtypes se...

    L Rickardson, M Fryknäs, S Dhar, H Lövborg, J Gullbo in British Journal of Cancer (2005)

previous disabled Page of 2